Alpha-thalassemia intellectual disability: Variable phenotypic expression among males with a recurrent nonsense mutation - c.109C>T (p.R37X)

M. J. Basehore, R. Michaelson-Cohen, E. Levy-Lahad, C. Sismani, L. M. Bird, M. J. Friez, T. Walsh, F. Abidi, L. Holloway, C. Skinner, S. Mcgee, A. Alexandrou, M. Syrrou, P. C. Patsalis, G. Raymond, T. Wang, C. E. Schwartz, M. C. King, R. E. Stevenson

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Alpha-thalassemia intellectual disability, one of the recognizable X-linked disability syndromes, is characterized by short stature, microcephaly, distinctive facies, hypotonic appearance, cardiac and genital anomalies, and marked skewing of X-inactivation in female carriers. With the advent of next generation sequencing, mutations have been identified that result in less severe phenotypes lacking one or more of these phenotypic manifestations. Here we report five unrelated kindreds in which a c.109C>T (p.R37X) mutation segregates with a variable but overall milder phenotype. The distinctive facial appearance of alpha-thalassemia intellectual disability was present in only one of the 18 affected males evaluated beyond the age of puberty, although suggestive facial appearance was present in several during infancy or early childhood. Although the responsible genetic alteration is a nonsense mutation in exon 2 of ATRX, the phenotype appears to be partially rescued by the production of alternative transcripts and/or other molecular mechanisms.

Original languageEnglish (US)
Pages (from-to)461-466
Number of pages6
JournalClinical Genetics
Volume87
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

alpha-Thalassemia
Nonsense Codon
Intellectual Disability
Phenotype
X Chromosome Inactivation
Microcephaly
Mutation
Puberty
Exons

All Science Journal Classification (ASJC) codes

  • Genetics
  • Genetics(clinical)

Cite this

Basehore, M. J., Michaelson-Cohen, R., Levy-Lahad, E., Sismani, C., Bird, L. M., Friez, M. J., ... Stevenson, R. E. (2015). Alpha-thalassemia intellectual disability: Variable phenotypic expression among males with a recurrent nonsense mutation - c.109C>T (p.R37X). Clinical Genetics, 87(5), 461-466. https://doi.org/10.1111/cge.12420
Basehore, M. J. ; Michaelson-Cohen, R. ; Levy-Lahad, E. ; Sismani, C. ; Bird, L. M. ; Friez, M. J. ; Walsh, T. ; Abidi, F. ; Holloway, L. ; Skinner, C. ; Mcgee, S. ; Alexandrou, A. ; Syrrou, M. ; Patsalis, P. C. ; Raymond, G. ; Wang, T. ; Schwartz, C. E. ; King, M. C. ; Stevenson, R. E. / Alpha-thalassemia intellectual disability : Variable phenotypic expression among males with a recurrent nonsense mutation - c.109C>T (p.R37X). In: Clinical Genetics. 2015 ; Vol. 87, No. 5. pp. 461-466.
@article{46dca8ce552f4e31a3facb1db9446845,
title = "Alpha-thalassemia intellectual disability: Variable phenotypic expression among males with a recurrent nonsense mutation - c.109C>T (p.R37X)",
abstract = "Alpha-thalassemia intellectual disability, one of the recognizable X-linked disability syndromes, is characterized by short stature, microcephaly, distinctive facies, hypotonic appearance, cardiac and genital anomalies, and marked skewing of X-inactivation in female carriers. With the advent of next generation sequencing, mutations have been identified that result in less severe phenotypes lacking one or more of these phenotypic manifestations. Here we report five unrelated kindreds in which a c.109C>T (p.R37X) mutation segregates with a variable but overall milder phenotype. The distinctive facial appearance of alpha-thalassemia intellectual disability was present in only one of the 18 affected males evaluated beyond the age of puberty, although suggestive facial appearance was present in several during infancy or early childhood. Although the responsible genetic alteration is a nonsense mutation in exon 2 of ATRX, the phenotype appears to be partially rescued by the production of alternative transcripts and/or other molecular mechanisms.",
author = "Basehore, {M. J.} and R. Michaelson-Cohen and E. Levy-Lahad and C. Sismani and Bird, {L. M.} and Friez, {M. J.} and T. Walsh and F. Abidi and L. Holloway and C. Skinner and S. Mcgee and A. Alexandrou and M. Syrrou and Patsalis, {P. C.} and G. Raymond and T. Wang and Schwartz, {C. E.} and King, {M. C.} and Stevenson, {R. E.}",
year = "2015",
month = "5",
day = "1",
doi = "10.1111/cge.12420",
language = "English (US)",
volume = "87",
pages = "461--466",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell",
number = "5",

}

Basehore, MJ, Michaelson-Cohen, R, Levy-Lahad, E, Sismani, C, Bird, LM, Friez, MJ, Walsh, T, Abidi, F, Holloway, L, Skinner, C, Mcgee, S, Alexandrou, A, Syrrou, M, Patsalis, PC, Raymond, G, Wang, T, Schwartz, CE, King, MC & Stevenson, RE 2015, 'Alpha-thalassemia intellectual disability: Variable phenotypic expression among males with a recurrent nonsense mutation - c.109C>T (p.R37X)', Clinical Genetics, vol. 87, no. 5, pp. 461-466. https://doi.org/10.1111/cge.12420

Alpha-thalassemia intellectual disability : Variable phenotypic expression among males with a recurrent nonsense mutation - c.109C>T (p.R37X). / Basehore, M. J.; Michaelson-Cohen, R.; Levy-Lahad, E.; Sismani, C.; Bird, L. M.; Friez, M. J.; Walsh, T.; Abidi, F.; Holloway, L.; Skinner, C.; Mcgee, S.; Alexandrou, A.; Syrrou, M.; Patsalis, P. C.; Raymond, G.; Wang, T.; Schwartz, C. E.; King, M. C.; Stevenson, R. E.

In: Clinical Genetics, Vol. 87, No. 5, 01.05.2015, p. 461-466.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Alpha-thalassemia intellectual disability

T2 - Variable phenotypic expression among males with a recurrent nonsense mutation - c.109C>T (p.R37X)

AU - Basehore, M. J.

AU - Michaelson-Cohen, R.

AU - Levy-Lahad, E.

AU - Sismani, C.

AU - Bird, L. M.

AU - Friez, M. J.

AU - Walsh, T.

AU - Abidi, F.

AU - Holloway, L.

AU - Skinner, C.

AU - Mcgee, S.

AU - Alexandrou, A.

AU - Syrrou, M.

AU - Patsalis, P. C.

AU - Raymond, G.

AU - Wang, T.

AU - Schwartz, C. E.

AU - King, M. C.

AU - Stevenson, R. E.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Alpha-thalassemia intellectual disability, one of the recognizable X-linked disability syndromes, is characterized by short stature, microcephaly, distinctive facies, hypotonic appearance, cardiac and genital anomalies, and marked skewing of X-inactivation in female carriers. With the advent of next generation sequencing, mutations have been identified that result in less severe phenotypes lacking one or more of these phenotypic manifestations. Here we report five unrelated kindreds in which a c.109C>T (p.R37X) mutation segregates with a variable but overall milder phenotype. The distinctive facial appearance of alpha-thalassemia intellectual disability was present in only one of the 18 affected males evaluated beyond the age of puberty, although suggestive facial appearance was present in several during infancy or early childhood. Although the responsible genetic alteration is a nonsense mutation in exon 2 of ATRX, the phenotype appears to be partially rescued by the production of alternative transcripts and/or other molecular mechanisms.

AB - Alpha-thalassemia intellectual disability, one of the recognizable X-linked disability syndromes, is characterized by short stature, microcephaly, distinctive facies, hypotonic appearance, cardiac and genital anomalies, and marked skewing of X-inactivation in female carriers. With the advent of next generation sequencing, mutations have been identified that result in less severe phenotypes lacking one or more of these phenotypic manifestations. Here we report five unrelated kindreds in which a c.109C>T (p.R37X) mutation segregates with a variable but overall milder phenotype. The distinctive facial appearance of alpha-thalassemia intellectual disability was present in only one of the 18 affected males evaluated beyond the age of puberty, although suggestive facial appearance was present in several during infancy or early childhood. Although the responsible genetic alteration is a nonsense mutation in exon 2 of ATRX, the phenotype appears to be partially rescued by the production of alternative transcripts and/or other molecular mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=84927017162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927017162&partnerID=8YFLogxK

U2 - 10.1111/cge.12420

DO - 10.1111/cge.12420

M3 - Article

C2 - 24805811

AN - SCOPUS:84927017162

VL - 87

SP - 461

EP - 466

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

IS - 5

ER -